Literature DB >> 9219457

Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.

T Markestad1, P Bergsjø, A Aakvaag, R T Lie, G Jacobsen, H J Hoffman, L S Bakketeig.   

Abstract

BACKGROUND: The purpose was to determine the usefulness of maternal serum concentrations of human chorionic gonadotropin (hCG), human placental lactogen (hPL) and estriol as predictors of fetal growth.
METHOD: From a large cohort serum obtained serially at 17, 25, 33 and 37 weeks of gestation were analyzed for randomly selected pregnancies resulting in small for gestational age (SGA, n = 102) and non-SGA (n = 112) infants.
RESULTS: There were no significant correlations between birthweight ratio (ratio of birthweight to mean weight for gestational age) and hCG, but between birthweight ratio on one hand and estriol for all stages of pregnancy (r = 0.19-0.38, p < 0.01 - p < 0.001) and hCL except at 33 weeks (r = 0.11-0.40, p ns-p < 0.001) on the other. There were statistically significant, but small median differences and substantial overlaps between the SGA and non-SGA infants for hCG at 17 and 37 weeks, for hPL at 17, 33 and 37 weeks, and for estriol at all the stages of pregnancy. The sensitivity and positive predictive value of low hormone concentrations (below the 10th percentile) in predicting the birth of an SGA infant were in the range of 6-26% and 17-39%, respectively. The corresponding specificity and prediction of a non-SGA infant from normal levels were 91-93% and 85-88%.
CONCLUSIONS: HPL and estriol, but not hCG concentrations, are positively related to the size of the fetus, but the relationships are too weak to be of predictive value in an unselected population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219457

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand Suppl        ISSN: 0300-8835


  10 in total

1.  Autism Spectrum Disorder Risk in Relation to Maternal Mid-Pregnancy Serum Hormone and Protein Markers from Prenatal Screening in California.

Authors:  Gayle C Windham; Kristen Lyall; Meredith Anderson; Martin Kharrazi
Journal:  J Autism Dev Disord       Date:  2016-02

Review 2.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

Authors:  Rachel K Morris; Jeltsje S Cnossen; Marloes Langejans; Stephen C Robson; Jos Kleijnen; Gerben Ter Riet; Ben W Mol; Joris A M van der Post; Khalid S Khan
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-04       Impact factor: 3.007

3.  Identification of messenger RNA of fetoplacental source in maternal plasma of women with normal pregnancies and pregnancies with intrauterine growth restriction.

Authors:  Paola Ayala Ramírez; Reggie García Robles; Juan Diego Rojas; Martha Bermúdez; Jaime Bernal
Journal:  Colomb Med (Cali)       Date:  2012-09-30

4.  Associations of Maternal Exposure to Dichlorodiphenyltrichloroethane and Pyrethroids With Birth Outcomes Among Participants in the Venda Health Examination of Mothers, Babies and Their Environment Residing in an Area Sprayed for Malaria Control.

Authors:  Jonathan Chevrier; Stephen Rauch; Madelein Crause; Muvhulawa Obida; Fraser Gaspar; Riana Bornman; Brenda Eskenazi
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

5.  Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction.

Authors:  Osnat Ashur-Fabian; Gil M Yerushalmi; Shali Mazaki-Tovi; David M Steinberg; Inbal Goldshtein; Michal Yackobovitch-Gavan; Eyal Schiff; Ninette Amariglio; Gideon Rechavi
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

6.  Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.

Authors:  Alexander Ep Heazell; Dexter Jl Hayes; Melissa Whitworth; Yemisi Takwoingi; Susan E Bayliss; Clare Davenport
Journal:  Cochrane Database Syst Rev       Date:  2019-05-14

Review 7.  Developmental origins of metabolic diseases.

Authors:  Daniel J Hoffman; Theresa L Powell; Emily S Barrett; Daniel B Hardy
Journal:  Physiol Rev       Date:  2020-12-03       Impact factor: 46.500

8.  The vitamin E-binding protein afamin increases in maternal serum during pregnancy.

Authors:  Michael Hubalek; Hannes Buchner; Manfred G Mörtl; Dietmar Schlembach; Berthold Huppertz; Branka Firulovic; Wolfgang Köhler; Erich Hafner; Benjamin Dieplinger; Ludwig Wildt; Hans Dieplinger
Journal:  Clin Chim Acta       Date:  2014-04-24       Impact factor: 3.786

Review 9.  Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives.

Authors:  Rafał Sibiak; Maurycy Jankowski; Paweł Gutaj; Paul Mozdziak; Bartosz Kempisty; Ewa Wender-Ożegowska
Journal:  J Clin Med       Date:  2020-04-16       Impact factor: 4.241

10.  Prediction of low birth weight with hypoglycemia in glucose tolerance test.

Authors:  Flavio Hernández-Castro; Anaís Berlanga-Garza; Mayela Diamantina Cruz-Gutiérrez; Juan Antonio Soria-López; Gabriel Edgar Villagómez-Martínez; Iván Vladimir Dávila-Escamilla
Journal:  Rev Saude Publica       Date:  2021-05-17       Impact factor: 2.106

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.